Livongo Health (NASDAQ:LVGO) Earns Equal Weight Rating from Analysts at Morgan Stanley

Morgan Stanley assumed coverage on shares of Livongo Health (NASDAQ:LVGO) in a research note issued to investors on Monday morning, BenzingaRatingsTable reports. The firm issued an equal weight rating and a $42.00 target price on the stock.

LVGO has been the topic of several other research reports. Canaccord Genuity started coverage on Livongo Health in a research note on Monday. They issued a buy rating and a $46.00 price objective on the stock. JPMorgan Chase & Co. started coverage on Livongo Health in a research note on Monday. They issued an overweight rating and a $43.00 price objective on the stock. Leerink Swann started coverage on Livongo Health in a research note on Monday. They issued an outperform rating and a $50.00 price objective on the stock. KeyCorp started coverage on Livongo Health in a research note on Monday. They issued an overweight rating and a $46.00 price objective on the stock. Finally, Piper Jaffray Companies started coverage on Livongo Health in a research note on Monday. They issued an overweight rating and a $40.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Livongo Health has a consensus rating of Buy and a consensus price target of $44.20.

Shares of NASDAQ LVGO opened at $34.95 on Monday. Livongo Health has a twelve month low of $31.60 and a twelve month high of $45.68.



In related news, Director Hemant Taneja bought 2,678,571 shares of the company’s stock in a transaction on Monday, July 29th. The shares were purchased at an average price of $28.00 per share, for a total transaction of $74,999,988.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Ab (Publ) Kinnevik bought 3,141,795 shares of the company’s stock in a transaction on Monday, July 29th. The shares were bought at an average price of $28.00 per share, for a total transaction of $87,970,260.00. The disclosure for this purchase can be found here.

Livongo Health Company Profile

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Further Reading: Return on Equity (ROE)

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.